Literature DB >> 21981840

High-density lipoprotein cholesterol in diabetes: is higher always better?

Tina Costacou1, Rhobert W Evans, Trevor J Orchard.   

Abstract

BACKGROUND: Recent data suggest that highly elevated high-density lipoprotein cholesterol (HDL-C) may not always protect against cardiovascular disease. To what degree this is true in type 1 diabetes is unknown, although cardiovascular risk is increased despite elevated mean HDL-C.
OBJECTIVE: To reassess the association between HDL-C and its subfractions with coronary artery disease (CAD) in childhood-onset type 1 diabetes.
METHODS: Epidemiology of Diabetes Complications study participants free of CAD at baseline (301 men, 298 women; mean age, 27.1 and diabetes duration, 18.9 years) were studied. CAD was defined as angina, ischemic electrocardiogram changes, confirmed myocardial infarction, angiographic stenosis ≥50%, revascularization, or CAD death. Cholesterol in the HDL fraction and HDL3 cholesterol subfraction was measured enzymatically after precipitation with heparin/manganese and dextran sulfate, respectively.
RESULTS: During 18 years of follow-up, 29.5% of men and 25.5% of women developed CAD. Although a linear decrease in incidence was observed with increasing HDL-C concentration in men, incidence increased in women at less than 47 mg/dL and greater than 80 mg/dL. These patterns largely reflected the HDL3 cholesterol-CAD association. After multivariable adjustment, the linear, inverse, HDL-C/CAD association persisted in men (hazard ratio [HR] 0.97, 95% confidence interval [CI] 0.94-0.99); in women, the U-shaped relationship lost significance. HDL3 cholesterol remained multivariably associated with CAD in both men (linear association, P = .03) and women (HR 2.31 (95% CI 1.31-4.08) and HR 1.80 (95% CI 1.01-3.23) for the lowest and highest versus the middle quintiles, respectively).
CONCLUSION: The increased CAD risk in women for an HDL-C >80 mg/dL in type 1 diabetes merits further study. Gender specificity could not be determined as only two men had HDL-C >80 mg/dL.
Copyright © 2011 National Lipid Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21981840      PMCID: PMC3190122          DOI: 10.1016/j.jacl.2011.06.011

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN: 1876-4789            Impact factor:   4.766


  31 in total

Review 1.  HDL and arteriosclerosis: beyond reverse cholesterol transport.

Authors:  Jerzy-Roch Nofer; Beate Kehrel; Manfred Fobker; Bodo Levkau; Gerd Assmann; Arnold von Eckardstein
Journal:  Atherosclerosis       Date:  2002-03       Impact factor: 5.162

2.  Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels.

Authors:  Steven A Grover; Mohammed Kaouache; Lawrence Joseph; Philip Barter; Jean Davignon
Journal:  Arch Intern Med       Date:  2009-10-26

Review 3.  High-density lipoprotein subpopulations in pathologic conditions.

Authors:  Bela F Asztalos; Ernst J Schaefer
Journal:  Am J Cardiol       Date:  2003-04-03       Impact factor: 2.778

4.  Enzymatic determination of total serum cholesterol.

Authors:  C C Allain; L S Poon; C S Chan; W Richmond; P C Fu
Journal:  Clin Chem       Date:  1974-04       Impact factor: 8.327

5.  Quantitative determination of serum triglycerides by the use of enzymes.

Authors:  G Bucolo; H David
Journal:  Clin Chem       Date:  1973-05       Impact factor: 8.327

6.  New approach to evaluation of proteinuric states.

Authors:  D Ellis; G J Buffone
Journal:  Clin Chem       Date:  1977       Impact factor: 8.327

7.  Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study.

Authors:  Trevor J Orchard; Jon C Olson; John R Erbey; Katherine Williams; Kimberly Y-Z Forrest; Leslie Smithline Kinder; Demetrius Ellis; Dorothy J Becker
Journal:  Diabetes Care       Date:  2003-05       Impact factor: 19.112

8.  Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein.

Authors:  Radjesh J Bisoendial; G Kees Hovingh; Johannes H M Levels; Peter G Lerch; Irmgard Andresen; Michael R Hayden; John J P Kastelein; Erik S G Stroes
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

9.  Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.

Authors:  S S Soedamah-Muthu; Y-F Chang; J Otvos; R W Evans; T J Orchard
Journal:  Diabetologia       Date:  2003-05-13       Impact factor: 10.122

10.  The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study.

Authors:  N E Miller; D S Thelle; O H Forde; O D Mjos
Journal:  Lancet       Date:  1977-05-07       Impact factor: 79.321

View more
  23 in total

Review 1.  Treatment of Dyslipidemia in Diabetes: Recent Advances and Remaining Questions.

Authors:  Alan Chait; Ira Goldberg
Journal:  Curr Diab Rep       Date:  2017-09-27       Impact factor: 4.810

Review 2.  Haptoglobin genotype and its role in diabetic cardiovascular disease.

Authors:  Tina Costacou; Andrew P Levy
Journal:  J Cardiovasc Transl Res       Date:  2012-03-24       Impact factor: 4.132

Review 3.  HDL: to treat or not to treat?

Authors:  Angela Pirillo; Gianpaolo Tibolla; Giuseppe Danilo Norata; Alberico Luigi Catapano
Journal:  Curr Atheroscler Rep       Date:  2014-08       Impact factor: 5.113

4.  Data-driven metabolic subtypes predict future adverse events in individuals with type 1 diabetes.

Authors:  Raija Lithovius; Iiro Toppila; Valma Harjutsalo; Carol Forsblom; Per-Henrik Groop; Ville-Petteri Mäkinen
Journal:  Diabetologia       Date:  2017-04-24       Impact factor: 10.122

5.  The role of pollutants in type 2 diabetes mellitus (T2DM) and their prospective impact on phytomedicinal treatment strategies.

Authors:  John Baptist Nzukizi Mudumbi; Seteno Karabo Obed Ntwampe; Lukhanyo Mekuto; Tandi Matsha; Elie Fereche Itoba-Tombo
Journal:  Environ Monit Assess       Date:  2018-04-02       Impact factor: 2.513

Review 6.  Patient selection and vitamin E treatment in diabetes mellitus.

Authors:  Hagit Goldenstein; Nina S Levy; Yisrael T Lipener; Andrew P Levy
Journal:  Expert Rev Cardiovasc Ther       Date:  2013-03

Review 7.  Glucose Management and the Sex Difference in Excess Cardiovascular Disease Risk in Long-Duration Type 1 Diabetes.

Authors:  Rachel G Miller; Tina Costacou
Journal:  Curr Diab Rep       Date:  2019-11-21       Impact factor: 4.810

8.  HDL particle size is increased and HDL-cholesterol efflux is enhanced in type 1 diabetes: a cross-sectional study.

Authors:  Mohamad O Ahmed; Rachel E Byrne; Agnieszka Pazderska; Ricardo Segurado; Weili Guo; Anjuli Gunness; Isolda Frizelle; Mark Sherlock; Khalid S Ahmed; Anne McGowan; Kevin Moore; Gerard Boran; Fiona C McGillicuddy; James Gibney
Journal:  Diabetologia       Date:  2020-11-09       Impact factor: 10.122

9.  Heterogeneous behavior of lipids according to HbA1c levels undermines the plausibility of metabolic syndrome in type 1 diabetes: data from a nationwide multicenter survey.

Authors:  Fernando M A Giuffrida; Alexis D Guedes; Eloa R Rocco; Denise B Mory; Patricia Dualib; Odelisa S Matos; Reine M Chaves-Fonseca; Roberta A Cobas; Carlos Antonio Negrato; Marilia B Gomes; Sergio A Dib
Journal:  Cardiovasc Diabetol       Date:  2012-12-27       Impact factor: 9.951

10.  Differential effect of glycemia on the incidence of hypertension by sex: the epidemiology of diabetes complications study.

Authors:  Tina Costacou; Trevor J Orchard
Journal:  Diabetes Care       Date:  2012-09-10       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.